Aquentium, Inc. (OTCQB: AQNM), a manufacturer of ozone air and water
purification systems for commercial businesses, announced today that the
company will begin manufacturing ozone air and water purification
equipment designed for use by legal growers of medical marijuana in the
United States and internationally.
"Aquentium believes that America is at the beginning of a 'Green Rush,'
an ever-increasing interest in the rapidly growing industry surrounding
what seems to be the beginning of the end of marijuana prohibition.
There are now 18 states that permit medical marijuana for people
suffering from a multitude of serious illnesses and disorders, while
residents in the state of Washington and the state of Colorado have
already voted for legalization regarding recreational use," stated
Aquentium President Mark Taggatz.
The Aquentium ozone air systems are designed to eliminate unwanted
odors, while the Aquentium water systems are designed to enhance growing
by killing germs and diseases. Treating water with ozone will kill
damaging bacteria and will sterilize the root base and growing media
while providing roots with extra oxygen.
"Ozone is one of the most effective bactericides known. Waterborne
diseases are controlled by the injected ozone, which destroys fungi,
pathogenic bacteria, viruses and organochlorines. These disease-causing
microbes can greatly reduce plant growth and yields or even destroy
entire crops. Once it has done its job, any excess ozone will break down
into oxygen, which super oxygenates the nutrient solution, promoting
rapid healthy root development. Ozone is not harmful to beneficial
aerobic bacteria that thrive in an oxygen-rich environment. Plants grow
faster and healthier, producing higher yields," added Taggatz.
Proponents of medical marijuana argue that it can be a safe and
effective treatment for the symptoms of cancer, AIDS, multiple
sclerosis, pain, glaucoma, epilepsy, and other conditions. They cite
dozens of peer-reviewed studies, prominent medical organizations, and
the use of marijuana as medicine throughout world history.
Safe Harbor Statement: Certain statements in this news release may
contain "forward-looking" information within the meaning of rule 175
under the Securities Act of 1933 and Rule 3b-6 under the Securities Act
of 1934 and are subject to the safe harbor created by those rules. There
can be no assurance that such forward-looking statements will be
accurate and actual results and future events could differ materially
from those anticipated in such statements.
Mark Taggatz, President